EZRA (EZRA) Surges 17.02% Intraday on Strategic Rebrand and AI-Healthcare Push

Reliance Global’s share price climbed to its highest level so far this month, surging 17.02% intraday on Jan. 24, marking a 16.26% gain over two days. The rally followed the company’s announcement of a strategic rebranding to “EZRA” and the formation of a new technology-focused division, signaling a pivot toward AI and healthcare innovation.

The company, formerly known as Reliance Global Group, revealed plans to rebrand its ticker symbol from “RELI” to “EZRA” effective Jan. 26, 2026. This shift underscores its transition from an InsurTech-centric model to a diversified technology growth strategy. Central to the move is the creation of the EZRA International Group, a division dedicated to acquiring stakes in high-potential tech firms. The first target is Scentech, an AI diagnostics company specializing in non-invasive breath-based disease detection. The acquisition, structured around clinical and regulatory milestones, aligns with the firm’s goal to leverage disruptive technologies in sectors like cybersecurity, AI, and digital health.

The strategic pivot aims to diversify revenue streams beyond insurance, where the company’s existing platform generates stable cash flows. By integrating Scentech’s AI-driven diagnostics, Reliance Global seeks to expand into healthcare innovation while mitigating financial risk through milestone-based funding. The rebranding is expected to enhance investor perception, attract capital for future acquisitions, and position the firm as a cross-sector technology and insurance holding company. However, challenges include regulatory hurdles and integration complexities in emerging markets. The stock’s recent surge reflects investor optimism about the firm’s long-term growth potential, though execution risks remain tied to the success of its tech-driven strategy.